# Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations

> **NCT01574898** · PHASE1 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 13 (actual)

## Conditions studied

- Healthy Smokers

## Interventions

- **DRUG:** V0474 - A mg
- **DRUG:** V0474 - B mg
- **DRUG:** V0474 - C mg
- **DRUG:** V0018 - B mg
- **DRUG:** Niquitin® Fresh Mint 4 mg

## Key facts

- **NCT ID:** NCT01574898
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01574898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01574898, "Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01574898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*